. 1997 Jan 21;94(2):646–651. doi: 10.1073/pnas.94.2.646

Table 1.

Effect of soluble hIgG on the phenotype of lymphocytes from secondary lymphoid tissue

Treatment	Blood		Lymph node		Spleen		Spleen (permeabilized)
Treatment	% hIgM (mean fl)	% B220	% hIgM (mean fl)	% B220	% hIgM (mean fl)	% B220	% hIgM (mean fl)
None	9.4 ± 0.7	15.1 ± 1.3	13.1 ± 0.9	16.1 ± 1.8	20.9 ± 1.5	37.9 ± 2.4	29.9 ± 4.1
None	(320)		(680)		(751)		(283)
12 h	4.1 ± 0.6^*	8.3 ± 0.7	14.9 ± 4.0	21.1 ± 3.5	23.0 ± 4.3	36.6 ± 3.5	33.7 ± 4.5
12 h	(105)^*		(138)^*		(200)^*		(381)
24 h	3.0 ± 0.5^*	6.8 ± 0.7	15.4 ± 2.1	27.5 ± 5.7^*	32.3 ± 3.2^*	42.8 ± 1.9	39.3 ± 4.9
24 h	(121)^*		(177)^*		(279)^*		(551)
4 days	2.9 ± 0.6^*	6.5 ± 0.5	5.1 ± 1.5^*	12.2 ± 0.7	8.7 ± 1.5^*	25.6 ± 3.1^*	14.4 ± 3.4^*
4 days	(134)^*		(203)^*		(257)^*		(367)
7 days	3.4 ± 1.9^*	6.1 ± 2.4	4.7 ± 1.6^*	9.4 ± 2.9	6.8 ± 1.8^*	22.2 ± 2.4^*	9.9 ± 1.2^*
7 days	(232)^*		(283)^*		(365)^*		(276)

AB29 mice were injected i.p. with 2 mg DHGG and killed at various times after treatment. Lymphoid cells from spleen and blood were stained for expression of either B220 (total B cells) or hIgM and then analyzed on the cytofluorograph. Data are expressed as mean percentage positive cells ± SE and mean fluorescence (in parentheses) for groups of three mice.

P < 0.05.